This morning (20th), the HSI opened up 284 pts and hovered near the peak level. It once rallied nearly 350 pts in the afternoon before trimming gains late in the session. The index closed at 25,698, up 203 pts or 0.8%, with turnover at HKD269.119 billion. The HSCEI closed at 8,547, up 76 pts or 0.9%. The HSTECH closed at 4,700 pts, up 18 pts or 0.39%.

Among major dotcoms, KUAISHOU-W (01024.HK) -4.160 (-11.005%) Short selling $2.34B; Ratio 27.795% slumped 11.01%, making it the worst-performing blue chip, after the company's 2Q adjusted profit slid 30.3% YoY and Daiwa downgraded the stock to Hold. TENCENT (00700.HK) +4.200 (+0.939%) Short selling $1.18B; Ratio 13.295% rose nearly 1%; BABA-W (09988.HK) +2.000 (+1.610%) Short selling $2.48B; Ratio 21.279% gained 1.61% ahead of results; BIDU-SW (09888.HK) +2.200 (+2.446%) Short selling $449.80M; Ratio 28.155% rebounded 2.45%; JD-SW (09618.HK) +1.900 (+1.687%) Short selling $320.25M; Ratio 25.401% mounted 1.69%.

For pharmaceuticals, SBP GROUP (01177.HK) +0.600 (+12.526%) Short selling $377.73M; Ratio 17.900% swelled 12.53%, becoming the best-performing blue chip of the day, after its interim profit added 1.4% and far exceeded expectations, prompting bullish comments from multiple brokers. WUXI BIO (02269.HK) +1.740 (+3.633%) Short selling $504.55M; Ratio 14.317% , INNOVENT BIO (01801.HK) +2.950 (+3.003%) Short selling $422.29M; Ratio 15.648% , WUXI APPTEC (02359.HK) +4.600 (+2.277%) Short selling $711.96M; Ratio 33.548% , HANSOH PHARMA (03692.HK) +0.700 (+2.122%) Short selling $108.55M; Ratio 16.529% and BEONE MEDICINES (06160.HK) +4.200 (+1.878%) Short selling $267.29M; Ratio 16.063% hiked more than 1-3%. HENGRUI PHARMA (01276.HK) -5.290 (-9.627%) Short selling $504.53M; Ratio 35.265% bucked the market and dived 9.63% after brokers said its quarterly results missed.

Moderna, Inc. (MRNA.US) leapfrogged 176% overnight after its mRNA cancer vaccine achieved a major breakthrough in late-stage clinical trials. The news boosted innovative drug concept stocks. EVEREST MED (01952.HK) +9.860 (+41.429%) Short selling $296.16M; Ratio 6.938% skyrocketed 41.43% to close at HKD33.66, with turnover surging to HKD4.269 billion. CANSINOBIO (06185.HK) +8.720 (+37.361%) Short selling $89.52M; Ratio 6.424% jumped up 37.36%; 3D MEDICINES (01244.HK) +1.240 (+56.881%) soared 56.88%; GENSCRIPT BIO (01548.HK) +4.000 (+13.624%) Short selling $412.96M; Ratio 10.901% spiked 13.62%; CSPC PHARMA (01093.HK) +0.835 (+9.614%) Short selling $478.25M; Ratio 11.096% swelled 9.61% after reporting an almost 1.4x leap in interim profit and raising its DPS by 28.6% to HKD0.18.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-08-20 16:25.) (Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)